Abbott's Q3 Earnings Release Coming Up, EPD Business in Focus [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
The company delivered adjusted earnings per share (EPS) of $1.14 in the last quarter, which topped the Zacks Consensus Estimate by 3.64%. In the trailing four quarters, its earnings exceeded the Zacks Consensus Estimate on all four occasions, the average beat being 2.34%. Q3 Estimates The Zacks Consensus Estimate for ABT's third-quarter 2024 revenues is pegged at $10.56 billion. This suggests a 4.1% rise from the year-ago reported figure. The Zacks Consensus Estimate for its third-quarter 2024 EPS of $1.20 indicates a 5.3% improvement from the 2023 comparable figure. Estimate Revision Trend Ahead of Earnings Estimates for Abbott's Q3 earnings remained unchanged at $1.20 per share in the past 60 days. Find the latest EPS estimates and surprises on Zacks Earnings Calendar Abbott Laboratories Price and EPS Surprise Abbott Laboratories price-eps-surprise | Abbott Laboratories Quote Let's briefly look at how things have progressed for the MedTech major leading up to this
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Cardiac Marker Tests Pipeline Report Featuring 230+ Companies and Prospective Products by Stages of Development, Segments, Region and Countries, Regulatory Path [Yahoo! Finance]Yahoo! Finance
- 4 Healthcare Technology Innovators to Invest in Before the New Year [Yahoo! Finance]Yahoo! Finance
- Reasons to Retain ABT Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- 2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond [Yahoo! Finance]Yahoo! Finance
- ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 11/15/24 - Form 8-K
- 11/4/24 - Form 144
- 10/31/24 - Form 10-Q
- ABT's page on the SEC website